Global Hereditary Angioedema Market Outlook 2018-2025 : Industry Trends, Analysis, Opportunities, Sales, Segmentation, Revenue and Forecast


 Published Date : Oct-2018  |   Publisher : Reports Buzz  |   Format : PDF

 Buy Now

This report studies the global market size of Hereditary Angioedema in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Hereditary Angioedema in these regions.
This research report categorizes the global Hereditary Angioedema market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Hereditary angioedema is a rare disease and is mostly mistaken for common allergic reactions and abdominal pain. This mainly on account of the lack of knowledge among both physicians and patients about the condition. About 40% of the affected patients are diagnosed correctly with hereditary angioedema in the US and Europe. With progress in diagnostic field and different initiatives undertaken by patient bodies and industry players to spread awareness, the market for hereditary angioedema is projected to grow.
In 2017, the global Hereditary Angioedema market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Hereditary Angioedema market based on company, product type, application and key regions.

The various contributors involved in the value chain of Hereditary Angioedema include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Hereditary Angioedema include
    Pharming Group NV
    Shire plc
    CSL Limited
    iBio Inc.
    BioCryst Pharmaceuticals, Inc.
    Ionis Pharmaceuticals, Inc.

Market Size Split by Type
    C1 Esterase Inhibitor
    Kallikrein Inhibitor
    Selective Bradykinin B2 Receptor Antagonist
Market Size Split by Application
    Retail Pharmacies
    Hospital Pharmacies
    Online Pharmacies

Market size split by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Hereditary Angioedema market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
    To understand the structure of Hereditary Angioedema market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Hereditary Angioedema manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Hereditary Angioedema with respect to individual growth trends, future prospects, and their contribution to the total market.
    To project the value and volume of Hereditary Angioedema submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Hereditary Angioedema are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Hereditary Angioedema market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Study Coverage
    1.1  Hereditary Angioedema Product
    1.2 Key Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Hereditary Angioedema Market Size Growth Rate by Type
        1.4.2 C1 Esterase Inhibitor
        1.4.3 Kallikrein Inhibitor
        1.4.4 Selective Bradykinin B2 Receptor Antagonist
    1.5 Market by Application
        1.5.1 Global Hereditary Angioedema Market Size Growth Rate by Application
        1.5.2 Retail Pharmacies
        1.5.3 Hospital Pharmacies
        1.5.4 Online Pharmacies
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Hereditary Angioedema Market Size
        2.1.1 Global Hereditary Angioedema Revenue 2016-2025
        2.1.2 Global Hereditary Angioedema Sales 2016-2025
    2.2 Hereditary Angioedema Growth Rate by Regions
        2.2.1 Global Hereditary Angioedema Sales by Regions
        2.2.2 Global Hereditary Angioedema Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Hereditary Angioedema Sales by Manufacturers
        3.1.1 Hereditary Angioedema Sales by Manufacturers
        3.1.2 Hereditary Angioedema Sales Market Share by Manufacturers
        3.1.3 Global Hereditary Angioedema Market Concentration Ratio (CR5 and HHI)
    3.2 Hereditary Angioedema Revenue by Manufacturers
        3.2.1 Hereditary Angioedema Revenue by Manufacturers (2016-2018)
        3.2.2 Hereditary Angioedema Revenue Share by Manufacturers (2016-2018)
    3.3 Hereditary Angioedema Price by Manufacturers
    3.4 Hereditary Angioedema Manufacturing Base Distribution, Product Types
        3.4.1 Hereditary Angioedema Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Hereditary Angioedema Product Category
        3.4.3 Date of International Manufacturers Enter into Hereditary Angioedema  Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
    4.1 Global Hereditary Angioedema Sales by Type
    4.2 Global Hereditary Angioedema Revenue by Type
    4.3 Hereditary Angioedema Price by Type

5 Breakdown Data by Application
    5.1 Overview
    5.2 Global Hereditary Angioedema Breakdown Data by Application

6 North America
    6.1 North America Hereditary Angioedema by Countries
        6.1.1 North America Hereditary Angioedema Sales by Countries
        6.1.2 North America Hereditary Angioedema Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Hereditary Angioedema by Type
    6.3 North America Hereditary Angioedema by Application
    6.4 North America Hereditary Angioedema by Company

7 Europe
    7.1 Europe Hereditary Angioedema by Countries
        7.1.1 Europe Hereditary Angioedema Sales by Countries
        7.1.2 Europe Hereditary Angioedema Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Hereditary Angioedema by Type
    7.3 Europe Hereditary Angioedema by Application
    7.4 Europe Hereditary Angioedema by Company

8 Asia Pacific
    8.1 Asia Pacific Hereditary Angioedema by Countries
        8.1.1 Asia Pacific Hereditary Angioedema Sales by Countries
        8.1.2 Asia Pacific Hereditary Angioedema Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Hereditary Angioedema by Type
    8.3 Asia Pacific Hereditary Angioedema by Application
    8.4 Asia Pacific Hereditary Angioedema by Company

9 Central & South America
    9.1 Central & South America Hereditary Angioedema by Countries
        9.1.1 Central & South America Hereditary Angioedema Sales by Countries
        9.1.2 Central & South America Hereditary Angioedema Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Hereditary Angioedema by Type
    9.3 Central & South America Hereditary Angioedema by Application
    9.4 Central & South America Hereditary Angioedema by Company

10 Middle East and Africa
    10.1 Middle East and Africa Hereditary Angioedema by Countries
        10.1.1 Middle East and Africa Hereditary Angioedema Sales by Countries
        10.1.2 Middle East and Africa Hereditary Angioedema Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Hereditary Angioedema by Type
    10.3 Middle East and Africa Hereditary Angioedema by Application
    10.4 Middle East and Africa Hereditary Angioedema by Company

11 Company Profiles
    11.1 Pharming Group NV
        11.1.1 Pharming Group NV Company Details
        11.1.2 Company Description
        11.1.3 Sales, Revenue and Gross Margin of Hereditary Angioedema
        11.1.4 Hereditary Angioedema Product Description
        11.1.5 Recent Development
    11.2 Shire plc
        11.2.1 Shire plc Company Details
        11.2.2 Company Description
        11.2.3 Sales, Revenue and Gross Margin of Hereditary Angioedema
        11.2.4 Hereditary Angioedema Product Description
        11.2.5 Recent Development
    11.3 CSL Limited
        11.3.1 CSL Limited Company Details
        11.3.2 Company Description
        11.3.3 Sales, Revenue and Gross Margin of Hereditary Angioedema
        11.3.4 Hereditary Angioedema Product Description
        11.3.5 Recent Development
    11.4 iBio Inc.
        11.4.1 iBio Inc. Company Details
        11.4.2 Company Description
        11.4.3 Sales, Revenue and Gross Margin of Hereditary Angioedema
        11.4.4 Hereditary Angioedema Product Description
        11.4.5 Recent Development
    11.5 BioCryst Pharmaceuticals, Inc.
        11.5.1 BioCryst Pharmaceuticals, Inc. Company Details
        11.5.2 Company Description
        11.5.3 Sales, Revenue and Gross Margin of Hereditary Angioedema
        11.5.4 Hereditary Angioedema Product Description
        11.5.5 Recent Development
    11.6 Ionis Pharmaceuticals, Inc.
        11.6.1 Ionis Pharmaceuticals, Inc. Company Details
        11.6.2 Company Description
        11.6.3 Sales, Revenue and Gross Margin of Hereditary Angioedema
        11.6.4 Hereditary Angioedema Product Description
        11.6.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    12.1 Market Opportunities and Drivers
    12.2 Market Challenges
    12.3 Market Risks/Restraints
    12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
    13.1 Value Chain Analysis
        13.1.1 Typical Suppliers of Key Hereditary Angioedema Raw Material
        13.1.2 Hereditary Angioedema Customers
    13.2 Sales Channels Analysis
        13.2.1 Sales Channels Analysis
        13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            15.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Author Details
    15.3 Disclaimer



List of Tables and Figures

    Figure Picture of Hereditary Angioedema
    Figure Global Hereditary Angioedema Production (MT) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
    Figure Global Hereditary Angioedema Production Market Share by Types (Product Category) in 2017
    Figure C1 Esterase Inhibitor Product Picture
    Table Major Manufacturers of C1 Esterase Inhibitor
    Figure Kallikrein Inhibitor Product Picture
    Table Major Manufacturers of Kallikrein Inhibitor
    Figure Selective Bradykinin B2 Receptor Antagonist Product Picture
    Table Major Manufacturers of Selective Bradykinin B2 Receptor Antagonist
    Table Global Hereditary Angioedema Market Size Growth Rate by Application 2018-2025 (MT)
    Figure Retail Pharmacies
    Figure Hospital Pharmacies
    Figure Online Pharmacies
    Figure Hereditary Angioedema Report Years Considered
    Figure Global Hereditary Angioedema Market Size 2016-2025 (Million US$)
    Figure Global Hereditary Angioedema Sales 2016-2025 (MT)
    Table Global Hereditary Angioedema Market Size by Regions 2016-2025 (MT) & (Million US$)
    Table Global Hereditary Angioedema Sales by Regions 2016-2025 (MT)
    Table Global Hereditary Angioedema Sales Market Share by Regions 2016-2025
    Figure Global Hereditary Angioedema Sales Market Share by Regions 2016-2025
    Figure 2017 Global Hereditary Angioedema Sales Market Share by Regions
    Table Global Hereditary Angioedema Revenue by Regions 2016-2025 (Million US$)
    Table Global Hereditary Angioedema Revenue Market Share by Regions 2016-2025
    Figure Global Hereditary Angioedema Revenue Market Share by Regions 2016-2025
    Figure 2017 Global Hereditary Angioedema Revenue Market Share by Regions
    Table Global Hereditary Angioedema Sales by Manufacturers (2016-2018) (MT)
    Table Global Hereditary Angioedema Sales Share by Manufacturers (2016-2018)
    Figure Global Hereditary Angioedema Sales Share by Manufacturers in 2017
    Table Hereditary Angioedema Revenue by Manufacturers (2016-2018) (Million US$)
    Table Hereditary Angioedema Revenue Share by Manufacturers (2016-2018)
    Figure Hereditary Angioedema Value Share by Manufacturers in 2017
    Table Global Hereditary Angioedema Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Manufacturers Hereditary Angioedema Price (2016-2018) (USD/Kg)
    Table Hereditary Angioedema Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Hereditary Angioedema Product Category
    Table Date of International Manufacturers Enter into Hereditary Angioedema Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Hereditary Angioedema Sales by Type (2016-2025) (MT)
    Table Global Hereditary Angioedema Sales Share by Type (2016-2025)
    Figure Global Hereditary Angioedema Sales Market Share by Type (2016-2025)
    Figure Global Hereditary Angioedema Sales Market Share by Type in 2017
    Table Global Hereditary Angioedema Revenue by Type (2016-2025) (Million US$)
    Table Global Hereditary Angioedema Revenue Share by Type (2016-2025)
    Figure Global Hereditary Angioedema Revenue Market Share by Type (2016-2025)
    Figure Global Hereditary Angioedema Revenue Market Share by Type in 2017
    Table Hereditary Angioedema Price by Type 2013-2018 (USD/Kg)
    Table Global Hereditary Angioedema Sales by Application (2016-2025) (MT)
    Table Global Hereditary Angioedema Sales Share by Application (2016-2025)
    Figure Global Sales Hereditary Angioedema Market Share by Application (2016-2025)
    Figure Global Sales Hereditary Angioedema Market Share by Application (2016-2025)
    Figure North America Hereditary Angioedema Sales Growth Rate 2016-2025 (MT)
    Figure North America Hereditary Angioedema Revenue Growth Rate 2016-2025 (Million US$)
    Table North America Hereditary Angioedema Sales by Countries (2016-2025) (MT)
    Table North America Hereditary Angioedema Sales Market Share by Countries (2016-2025)
    Figure 2017 North America Hereditary Angioedema Sales Market Share by Countries
    Table North America Hereditary Angioedema Revenue by Countries (2016-2025) (Million US$)
    Table North America Hereditary Angioedema Revenue Market Share by Countries (2016-2025)
    Figure 2017 North America Hereditary Angioedema Revenue Market Share by Countries
    Figure United States Hereditary Angioedema Sales Growth Rate (2016-2025) (MT)
    Figure United States Hereditary Angioedema Revenue Growth Rate (2016-2025) (Million US$)
    Figure Canada Hereditary Angioedema Sales Growth Rate (2016-2025) (MT)
    Figure Canada Hereditary Angioedema Revenue Growth Rate (2016-2025) (Million US$)
    Figure Mexico Hereditary Angioedema Sales Growth Rate (2016-2025) (MT)
    Figure Mexico Hereditary Angioedema Revenue Growth Rate (2016-2025) (Million US$)
    Table North America Hereditary Angioedema Sales by Type (2016-2025) (MT)
    Table North America Hereditary Angioedema Sales Market Share by Type (2016-2025)
    Figure 2017 North America Hereditary Angioedema Market Share by Type
    Table North America Hereditary Angioedema Sales by Application (2016-2025) (MT)
    Table North America Hereditary Angioedema Sales Market Share by Application (2016-2025)
    Figure 2017 North America Hereditary Angioedema Market Share by Application
    Table North America Hereditary Angioedema Sales by Company (2016-2018) (MT)
    Table North America Hereditary Angioedema Sales Market Share by Company (2016-2018)
    Figure North America Hereditary Angioedema Sales Market Share by Company in 2017
    Figure Europe Hereditary Angioedema Sales Growth Rate 2016-2025 (MT)
    Figure Europe Hereditary Angioedema Revenue Growth Rate 2016-2025 (Million US$)
    Table Europe Hereditary Angioedema Sales by Countries (2016-2025) (MT)
    Table Europe Hereditary Angioedema Sales Market Share by Countries (2016-2025)
    Figure 2017 Europe Hereditary Angioedema Sales Market Share by Countries
    Table Europe Hereditary Angioedema Revenue by Countries (2016-2025) (Million US$)
    Table Europe Hereditary Angioedema Revenue Market Share by Countries (2016-2025)
    Figure 2017 Europe Hereditary Angioedema Revenue Market Share by Countries
    Figure Germany Hereditary Angioedema Sales Growth Rate (2016-2025) (MT)
    Figure Germany Hereditary Angioedema Revenue Growth Rate (2016-2025) (MT)
    Figure France Hereditary Angioedema Sales Growth Rate (2016-2025) (MT)
    Figure France Hereditary Angioedema Revenue Growth Rate (2016-2025) (MT)
    Figure UK Hereditary Angioedema Sales Growth Rate (2016-2025) (MT)
    Figure UK Hereditary Angioedema Revenue Growth Rate (2016-2025) (Million US$)
    Figure Italy Hereditary Angioedema Sales Growth Rate (2016-2025) (MT)
    Figure Italy Hereditary Angioedema Revenue Growth Rate (2016-2025) (Million US$)
    Figure Russia Hereditary Angioedema Sales Growth Rate (2016-2025) (MT)
    Figure Russia Hereditary Angioedema Revenue Growth Rate (2016-2025) (Million US$)
    Table Europe Hereditary Angioedema Sales by Type (2016-2025) (MT)
    Table Europe Hereditary Angioedema Sales Market Share by Type (2016-2025)
    Figure 2017 Europe Hereditary Angioedema Market Share by Type
    Table Europe Hereditary Angioedema Sales by Application (2016-2025) (MT)
    Table Europe Hereditary Angioedema Sales Market Share by Application (2016-2025)
    Figure 2017 Europe Hereditary Angioedema Market Share by Application
    Table Europe Hereditary Angioedema Sales by Company (2016-2018) (MT)
    Table Europe Hereditary Angioedema Sales Market Share by Company (2016-2018)
    Figure Europe Hereditary Angioedema Sales Market Share by Company in 2017
    Figure Asia Pacific Hereditary Angioedema Sales Growth Rate 2016-2025 (MT)
    Figure Asia Pacific Hereditary Angioedema Revenue Growth Rate 2016-2025 (Million US$)
    Table Asia Pacific Hereditary Angioedema Sales by Countries (2016-2025) (MT)
    Table Asia Pacific Hereditary Angioedema Sales Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Hereditary Angioedema Sales Market Share by Countries
    Table Asia Pacific Hereditary Angioedema Revenue by Countries (2016-2025) (Million US$)
    Table Asia Pacific Hereditary Angioedema Revenue Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Hereditary Angioedema Revenue Market Share by Countries
    Figure China Hereditary Angioedema Sales Growth Rate (2016-2025) (MT)
    Figure China Hereditary Angioedema Revenue Growth Rate (2016-2025) (Million US$)
    Figure Japan Hereditary Angioedema Sales Growth Rate (2016-2025) (MT)
    Figure Japan Hereditary Angioedema Revenue Growth Rate (2016-2025) (Million US$)
    Figure Korea Hereditary Angioedema Sales Growth Rate (2016-2025) (MT)
    Figure Korea Hereditary Angioedema Revenue Growth Rate (2016-2025) (Million US$)
    Figure India Hereditary Angioedema Sales Growth Rate (2016-2025) (MT)
    Figure India Hereditary Angioedema Revenue Growth Rate (2016-2025) (Million US$)
    Figure Australia Hereditary Angioedema Sales Growth Rate (2016-2025) (MT)
    Figure Australia Hereditary Angioedema Revenue Growth Rate (2016-2025) (Million US$)
    Figure Indonesia Hereditary Angioedema Sales Growth Rate (2016-2025) (MT)
    Figure Indonesia Hereditary Angioedema Revenue Growth Rate (2016-2025) (Million US$)
    Figure Malaysia Hereditary Angioedema Sales Growth Rate (2016-2025) (MT)
    Figure Malaysia Hereditary Angioedema Revenue Growth Rate (2016-2025) (Million US$)
    Figure Philippines Hereditary Angioedema Sales Growth Rate (2016-2025) (MT)
    Figure Philippines Hereditary Angioedema Revenue Growth Rate (2016-2025) (Million US$)
    Figure Thailand Hereditary Angioedema Sales Growth Rate (2016-2025) (MT)
    Figure Thailand Hereditary Angioedema Revenue Growth Rate (2016-2025) (Million US$)
    Figure Vietnam Hereditary Angioedema Sales Growth Rate (2016-2025) (MT)
    Figure Vietnam Hereditary Angioedema Revenue Growth Rate (2016-2025) (Million US$)
    Figure Singapore Hereditary Angioedema Sales Growth Rate (2016-2025) (MT)
    Figure Singapore Hereditary Angioedema Revenue Growth Rate (2016-2025) (Million US$)
    Table Asia Pacific Hereditary Angioedema Sales by Type (2016-2025) (MT)
    Table Asia Pacific Hereditary Angioedema Sales Market Share by Type (2016-2025)
    Figure 2017 Asia Pacific Hereditary Angioedema Market Share by Type
    Table Asia Pacific Hereditary Angioedema Sales by Application (2016-2025) (MT)
    Table Asia Pacific Hereditary Angioedema Sales Market Share by Application (2016-2025)
    Figure 2017 Asia Pacific Hereditary Angioedema Market Share by Application
    Table Asia Pacific Hereditary Angioedema Sales by Company (2016-2018) (MT)
    Table Asia Pacific Hereditary Angioedema Sales Market Share by Company (2016-2018)
    Figure Asia Pacific Hereditary Angioedema Sales Market Share by Company in 2017
    Figure Central & South America Hereditary Angioedema Sales Growth Rate 2016-2025 (MT)
    Figure Central & South America Hereditary Angioedema Revenue Growth Rate 2016-2025 (Million US$)
    Table Central & South America Hereditary Angioedema Sales by Countries (2016-2025) (MT)
    Table Central & South America Hereditary Angioedema Sales Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Hereditary Angioedema Sales Market Share by Countries
    Table Central & South America Hereditary Angioedema Revenue by Countries (2016-2025) (Million US$)
    Table Central & South America Hereditary Angioedema Revenue Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Hereditary Angioedema Revenue Market Share by Countries
    Figure Brazil Hereditary Angioedema Sales Growth Rate (2016-2025) (MT)
    Figure Brazil Hereditary Angioedema Revenue Growth Rate (2016-2025) (Million US$)
    Figure Argentina Hereditary Angioedema Sales Growth Rate (2016-2025) (MT)
    Figure Argentina Hereditary Angioedema Revenue Growth Rate (2016-2025) (Million US$)
    Table Central & South America Hereditary Angioedema Sales by Type (2016-2025) (MT)
    Table Central & South America Hereditary Angioedema Sales Market Share by Type (2016-2025)
    Figure 2017 Central & South America Hereditary Angioedema Market Share by Type
    Table Central & South America Hereditary Angioedema Sales by Application (2016-2025) (MT)
    Table Central & South America Hereditary Angioedema Sales Market Share by Application (2016-2025)
    Figure 2017 Central & South America Hereditary Angioedema Market Share by Application
    Table Central & South America Hereditary Angioedema Sales by Company (2016-2018) (MT)
    Table Central & South America Hereditary Angioedema Sales Market Share by Company (2016-2018)
    Figure Central & South America Hereditary Angioedema Sales Market Share by Company in 2017
    Figure Middle East and Africa Hereditary Angioedema Sales Growth Rate 2016-2025 (MT)
    Figure Middle East and Africa Hereditary Angioedema Revenue Growth Rate 2016-2025 (Million US$)
    Table Middle East and Africa Hereditary Angioedema Sales by Countries (2016-2025) (MT)
    Table Middle East and Africa Hereditary Angioedema Sales Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Hereditary Angioedema Sales Market Share by Countries
    Table Middle East and Africa Hereditary Angioedema Revenue by Countries (2016-2025) (Million US$)
    Table Middle East and Africa Hereditary Angioedema Revenue Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Hereditary Angioedema Revenue Market Share by Countries
    Figure GCC Countries Hereditary Angioedema Sales Growth Rate (2016-2025) (MT)
    Figure GCC Countries Hereditary Angioedema Revenue Growth Rate (2016-2025) (Million US$)
    Figure Turkey Hereditary Angioedema Sales Growth Rate (2016-2025) (MT)
    Figure Turkey Hereditary Angioedema Revenue Growth Rate (2016-2025) (Million US$)
    Figure Egypt Hereditary Angioedema Sales Growth Rate (2016-2025) (MT)
    Figure Egypt Hereditary Angioedema Revenue Growth Rate (2016-2025) (Million US$)
    Figure South Africa Hereditary Angioedema Sales Growth Rate (2016-2025) (MT)
    Figure South Africa Hereditary Angioedema Revenue Growth Rate (2016-2025) (Million US$)
    Table Middle East and Africa Hereditary Angioedema Sales by Type (2016-2025) (MT)
    Table Middle East and Africa Hereditary Angioedema Sales Market Share by Type (2016-2025)
    Figure 2017 Middle East and Africa Hereditary Angioedema Market Share by Type
    Table Middle East and Africa Hereditary Angioedema Sales by Application (2016-2025) (MT)
    Table Middle East and Africa Hereditary Angioedema Sales Market Share by Application (2016-2025)
    Figure 2017 Middle East and Africa Hereditary Angioedema Market Share by Application
    Table Middle East and Africa Hereditary Angioedema Sales by Company (2016-2018) (MT)
    Table Middle East and Africa Hereditary Angioedema Sales Market Share by Company (2016-2018)
    Figure Middle East and Africa Hereditary Angioedema Sales Market Share by Company in 2017
    Table Pharming Group NV Company Details
    Table Pharming Group NV Hereditary Angioedema Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
    Table Pharming Group NV Recent Development
    Table Shire plc Company Details
    Table Shire plc Hereditary Angioedema Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
    Table Shire plc Recent Development
    Table CSL Limited Company Details
    Table CSL Limited Hereditary Angioedema Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
    Table CSL Limited Recent Development
    Table iBio Inc. Company Details
    Table iBio Inc. Hereditary Angioedema Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
    Table iBio Inc. Recent Development
    Table BioCryst Pharmaceuticals, Inc. Company Details
    Table BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
    Table BioCryst Pharmaceuticals, Inc. Recent Development
    Table Ionis Pharmaceuticals, Inc. Company Details
    Table Ionis Pharmaceuticals, Inc. Hereditary Angioedema Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
    Table Ionis Pharmaceuticals, Inc. Recent Development
    Figure GDP by Regions / Largest Economies Pie Chart in 2016
    Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
    Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
    Figure Saving Rate Total, % of GDP, 2015
    Table Hereditary Angioedema Value Chain
    Table Typical Suppliers of Key Hereditary Angioedema Raw Material
    Table Hereditary Angioedema Customers List
    Table Hereditary Angioedema Sales Channels
    Table Hereditary Angioedema Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

LATEST NEWS

Microsoft And Walgreen Alliance To Help Healthcare Market To Propel
 25-Feb-2019  /   Chemicals & Materials

The alliance between two or more unrelated business organizations has been pushing the market to the next level by supporting each other. Currently, Amazon has been expanding its business into different markets at global level comprising its e-commerce business, cloud computing, and healthcare also. Amazon is frightening above mentioned markets-based players to tie up for future survival.

New Turmeric Product Is Going To Enter The Global Spices Market
 25-Feb-2019  /   Chemicals & Materials

An innovative agricultural product prepared from turmeric, specifically grown in Belize, has entered the market with high customer demand. The product is gaining popularity in Canada and other regions of the Caribbean, along with Belize. This might facilitate the steep growth of global spices market. This discovery will not only expand the agricultural market capitalization but also increase th ...

Drop In Cashew Export Owing To Quality Issues Likely To Hamper Cashew Market Growth
 13-Feb-2019  /   Food & Beverage

A major glut along with poor turnover was confronted by merchants, traders, farmers, and other financiers in the cashew market in Kogi State in the 2018 farming season caused by heavy losses summed over N50 Billion. Kogi is the largest cashew-making state in Nigeria, shipping around 100 metric tonnes of cashew nuts out of the 220 metric tonnes exported by the whole nation yearly.






Our Clients

We are here to help you Get in touch quickly.

48 hours! That’s all you need to get a detailed market research of any specific industry.

/